Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Citius Pharmaceuticals, Inc.

NASDAQ: CTXR · Life Sciences · 2 alerts · CIK 1506251

Share price
$0.5276Close, Nov 16
Market cap
$14.5M
Shares outstanding
27.45MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Citius Pharmaceuticals, Inc. filings on SEC EDGAR ↗

4:06 PM ET 8-K
Business Update

Citius Pharmaceuticals Business Update

Citius Pharmaceuticals' subsidiary, Citius Oncology, reported preliminary fiscal fourth quarter 2026 operational metrics for its drug LYMPHIR. The company saw a 120% increase in unit sales to wholesalers (792 units) and expanded its institutional reach to 54 ordering centers as it works toward a goal of 100 priority institutions by year-end.

Term
Q4 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.